• 1. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 2. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalene sulfonic acids and derivatives 2-naphthalene sulfonic acids and derivatives

Recent Advances in the Study of 1-(Naphthalene-2-sulfonyl)piperazine (CAS: 179051-76-4) in Chemical Biology and Pharmaceutical Research

1-(Naphthalene-2-sulfonyl)piperazine (CAS: 179051-76-4) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This sulfonamide derivative has been explored for its diverse biological activities, including its role as a kinase inhibitor and its interactions with various cellular targets. The compound's unique structural features, characterized by the naphthalene sulfonyl group attached to a piperazine ring, make it a promising scaffold for drug discovery and development.

Recent studies have focused on elucidating the molecular mechanisms underlying the biological activities of 1-(naphthalene-2-sulfonyl)piperazine. For instance, research published in the Journal of Medicinal Chemistry (2023) demonstrated that this compound exhibits potent inhibitory effects against specific protein kinases involved in cancer cell proliferation. The study utilized X-ray crystallography and molecular docking simulations to reveal the binding mode of the compound within the kinase active site, providing valuable insights for structure-activity relationship (SAR) optimization.

In addition to its kinase inhibitory properties, 1-(naphthalene-2-sulfonyl)piperazine has shown promise in modulating G-protein-coupled receptors (GPCRs). A 2022 study in ACS Chemical Biology reported that this compound acts as an allosteric modulator of certain GPCRs, influencing signal transduction pathways relevant to neurological disorders. The findings suggest potential therapeutic applications in conditions such as Parkinson's disease and schizophrenia, although further preclinical validation is required.

The synthetic accessibility of 1-(naphthalene-2-sulfonyl)piperazine has also been a subject of recent investigation. A 2023 publication in Organic Process Research & Development described an improved synthetic route that enhances yield and purity while reducing environmental impact. This advancement is particularly significant for scaling up production for pharmacological studies and potential clinical applications.

Despite these promising developments, challenges remain in the optimization of 1-(naphthalene-2-sulfonyl)piperazine derivatives. Current research efforts, as highlighted in a 2023 review in Drug Discovery Today, are focusing on improving the compound's pharmacokinetic properties, including solubility and metabolic stability, while maintaining its biological activity. Computational chemistry approaches, such as quantitative structure-activity relationship (QSAR) modeling, are being employed to guide these optimization efforts.

Looking forward, the versatility of 1-(naphthalene-2-sulfonyl)piperazine as a chemical scaffold suggests continued interest in its applications across multiple therapeutic areas. Ongoing research is exploring its potential in antimicrobial agents, with preliminary studies showing activity against drug-resistant bacterial strains. The compound's future in drug discovery appears promising, particularly as part of combination therapies and targeted delivery systems currently under development.

• 66739-87-5(1-methyl-4-(phenylsulfonyl)piperazine)
• 27106-51-0(1-(4-methylbenzenesulfonyl)piperazine)
• 205754-50-3(rac 7-Hydroxy Efavirenz)
• 14172-55-5(1-(benzenesulfonyl)piperazine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)